PATENT CLAIM ANALYSIS

Application Number: 15767609
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-11
Patent Classification: ["424", "206100"]

Abstract:
The disclosure relates to influenza virus ribonucleic acid (RNA) vaccines, as well as methods of using the vaccines and compositions comprising the vaccines.

Claim (Index 64):
A pharmaceutical composition for use in vaccination of a subject comprising an effective dose of mRNA encoding an influenza virus antigen,\n wherein the effective dose is sufficient to produce detectable levels of antigen as measured in serum of the subject at 1-72 hours post administration.

Metadata:
- Claim Count in Document: 92.0
- Percentile: 91.0
- Lexical Diversity: 1.17391
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15674599', '15091123', '15674591', '15674585', '14701065']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7684144098177268
- 35 USC 102 Novelty (BERT): 0.5635982127678264
- Combined Prediction Score: 0.7479327901127367
- Mean Citation Score: 431.615348
- Max Citation Score: 460.40488
- Similarity Product: 363.40617249856

Labels:
- Claim Label 101: 0
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test